CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project aims to develop combination therapies for Multiple Sclerosis by utilizing computational models that integrate biological data. By understanding the immune response and testing new compounds, it seeks to create more effective treatments for this complex disease and potentially other immune-related conditions…
The therapeutic challenge of complex diseases requires the use of combination therapies to target the distinct mechanisms and pathways involved.
Such complex diseases will benefit from the design of computational models adopting a systems perspective to integrate the knowledge generated by ‘omics technologies and clinical data.
Multiple Sclerosis is a prototypic debilitating complex disease in which an autoimmune attack is launched against the brain.
Current therapies for MS are far from effecti…
BIONURE FARMA SL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Barcelona
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Greece, GLYFADA
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Switzerland, ZURICH
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
